New York Doctor Joins Levaquin Lawsuit MDL
New York resident Marvin Watsky, M.D., represented by his Levaquin lawyer, filed one of the new Levaquin lawsuits on September 24, 2012. The case was originally proceeding in the U.S. District Court, Eastern District of New York, but was later transferred to the Levaquin MDL (multidistrict litigation) in Minnesota. Watsky claims that after being prescribed Levaquin, he experienced serious injuries related to Levaquin side effects. He seeks multiple damages.
Levaquin lawyer provides few details
In this complaint, the plaintiff’s Levaquin lawyer gives few details about the injuries allegedly suffered by the plaintiff. He states only that Dr. Watsky took Levaquin and was injured as a result.
Most plaintiffs who file Levaquin lawsuits, however, suffer some sort of tendon injury. A powerful antibiotic used to treat adults with bacterial lung, sinus, skin and urinary tract infections, Levaquin (levofloxacin) has been linked with tendonitis, tendon rupture, and tendon tears—particularly, rotator cuff tears.
A 2003 study in Italy, for example, showed that the most frequently reported serious reaction to drugs like Levaquin were tendon disorders, and that levofloxacin had the highest tendonitis reporting rate of these types of drugs. Researchers added that Levaquin ranked first for tendonitis reports during the same period in the World Health Organization’s adverse event database, with over 500 reports of levofloxacin-induced tendon disorders and ruptures.
Levaquin lawsuits claim failure to warn
So serious have the complaints been against manufacturer Ortho-McNeil Janssen Pharmaceuticals, Inc. (a subsidiary of Johnson & Johnson) that in 2005, the Illinois attorney General submitted a petition to the FDA requesting a black box warning be added to the label to highlight the seriousness of tendon injuries.
In 2006, public advocacy group Public Citizen joined the Attorney General’s petition, urging the FDA to require the black box warning based on the increase in reports of tendon injuries.
In July 2008, the FDA agreed and required that manufacturers add the black box warning to their products. The warnings were not actually added until several months later, however. Critics claimed that even with the added visibility of the warning, Ortho-McNeil failed to live up to its duties by not issuing “Dear Doctor” letters to warn physicians of the change.
Plaintiff claims manufacturer downplayed Levaquin side effects
Dr. Watsky claims that Ortho-McNeil aggressively marketed and sold Levaquin by “falsely misleading potential users about the products.” In his complaint, drawn up by his Levaquin lawyer, he states that the company’s advertising program sought to “sought to create the image, impression and belief by consumers and physicians that the use of Levaquin was safe for human use, had fewer side effects and adverse reactions than other antibiotic medications and would not interfere with daily life, even though the Defendants knew these to be false, and even though the Defendants had no reasonable grounds to believe them to be true.”
The plaintiff, through his Levaquin lawyer, adds that the defendants purposefully downplayed and understated the health hazards and risks associated with Levaquin. He brings counts of failure to warn, design defect, negligence, and negligence per se, and seeks general, punitive and exemplary damages.
- Drugs & Medications - Levaquin Oral. http://www.webmd.com/drugs/mono-8235-LEVOFLOXACIN+-+ORAL.aspx?drugid=14492&drugname=Levaquin+Oral&source=0
- Johnson & Johnson Settles 845 Levaquin Lawsuits. http://www.bloomberg.com/news/2012-11-01/johnson-johnson-reaches-settlement-in-845-levaquin-cases.html